Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.148 USD | 0.00% | +6.47% | -86.81% |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 17.1 | 38.96 | 59.78 | 5.017 | 3.833 | 4.922 | - |
Enterprise Value (EV) 1 | 17.1 | 38.96 | 59.78 | 5.017 | 3.833 | 4.922 | 4.922 |
P/E ratio | -0.72 x | -0.74 x | -3.55 x | -0.16 x | -0.04 x | -0.46 x | -1.35 x |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | 0.45 x | 1.71 x | 1.53 x | 0.1 x | 0.08 x | 0.1 x | 0.09 x |
EV / Revenue | 0.45 x | 1.71 x | 1.53 x | 0.1 x | 0.08 x | 0.1 x | 0.09 x |
EV / EBITDA | -1.67 x | -2.92 x | -4.06 x | -0.25 x | -0.3 x | -2.98 x | 10.9 x |
EV / FCF | - | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - | - |
Price to Book | 46.1 x | 3.87 x | 2.38 x | 0.92 x | - | - | - |
Nbr of stocks (in thousands) | 12.4 | 37.4 | 61.3 | 77.2 | 3,416 | 33,257 | - |
Reference price 2 | 1,382 | 1,042 | 975.0 | 65.00 | 1.122 | 0.1480 | 0.1480 |
Announcement Date | 3/26/20 | 3/25/21 | 3/17/22 | 3/28/23 | 3/21/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net sales 1 | 37.8 | 22.78 | 39.19 | 48.46 | 49.16 | 51.5 | 55.5 |
EBITDA 1 | -10.23 | -13.36 | -14.71 | -20.14 | -12.77 | -1.65 | 0.45 |
EBIT 1 | -15.62 | -18.54 | -16.43 | -25.34 | -17.94 | -7.111 | -4.284 |
Operating Margin | -41.33% | -81.37% | -41.93% | -52.28% | -36.48% | -13.81% | -7.72% |
Earnings before Tax (EBT) 1 | -17.9 | -16.7 | -16.09 | -28.52 | -20.6 | -8.62 | -5.722 |
Net income 1 | -17.86 | -34.21 | -16.7 | -28.85 | -37.62 | -8.62 | -5.722 |
Net margin | -47.24% | -150.16% | -42.63% | -59.53% | -76.52% | -16.74% | -10.31% |
EPS 2 | -1,925 | -1,400 | -275.0 | -416.0 | -29.44 | -0.3200 | -0.1100 |
Free Cash Flow | - | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 3/26/20 | 3/25/21 | 3/17/22 | 3/28/23 | 3/21/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 9.531 | 12.41 | 10.17 | 12.24 | 12.01 | 14.05 | 10.47 | 14.29 | 10.92 | 13.49 | 9.996 | 14.1 | 12.08 | 15.33 | 10.5 |
EBITDA 1 | -2.454 | -4.338 | -3.916 | -4.079 | -5.623 | -6.523 | -4.448 | -2.311 | -3.149 | -2.864 | -2.45 | - | -0.5 | 1.3 | -1.35 |
EBIT 1 | -2.657 | -4.429 | -4.206 | -5.055 | -7.651 | -8.427 | -5.291 | -3.872 | -3.697 | -5.076 | -3.682 | -1.384 | -1.779 | -0.232 | -2.55 |
Operating Margin | -27.88% | -35.7% | -41.37% | -41.32% | -63.71% | -59.97% | -50.55% | -27.1% | -33.85% | -37.63% | -36.83% | -9.82% | -14.73% | -1.51% | -24.29% |
Earnings before Tax (EBT) 1 | -3.262 | -5.207 | -4.759 | -5.588 | -8.404 | -9.775 | -5.848 | -4.837 | -4.574 | -5.341 | -4.028 | -1.815 | -2.226 | -0.518 | -2.85 |
Net income 1 | -3.285 | -5.279 | -4.993 | -5.611 | -8.387 | -9.861 | -5.849 | -4.868 | -4.589 | -5.326 | -4.028 | -1.815 | -2.226 | -0.518 | -2.85 |
Net margin | -34.47% | -42.55% | -49.11% | -45.86% | -69.83% | -70.18% | -55.88% | -34.08% | -42.02% | -39.48% | -40.29% | -12.88% | -18.42% | -3.38% | -27.14% |
EPS 2 | -50.00 | -75.00 | -77.00 | -91.00 | -110.0 | -128.0 | -18.00 | -8.930 | -3.890 | -1.760 | -0.1700 | -0.0500 | -0.0650 | -0.0300 | -0.0600 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/10/21 | 3/17/22 | 5/12/22 | 8/11/22 | 11/10/22 | 3/28/23 | 5/11/23 | 8/10/23 | 11/9/23 | 3/21/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share | 30.00 | 269.0 | 410.0 | 70.50 | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex 1 | 0.21 | 0.1 | 0.71 | 3.73 | 1.31 | 0.6 | 0.6 |
Capex / Sales | 0.55% | 0.42% | 1.8% | 7.69% | 2.67% | 1.17% | 1.08% |
Announcement Date | 3/26/20 | 3/25/21 | 3/17/22 | 3/28/23 | 3/21/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.81% | 4.92M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- BIOL Stock
- Financials BIOLASE, Inc.